1993
On May 8, 1993, the first batch of products of Heart K Group were launched on the market, with sales that year reaching 17 million yuan.
1994
At 3 o'clock in the morning on July 18, in an office in Building 5 of the Hubei Provincial Party Committee Courtyard, Chairman Xie Shengming, shirtless, worked hard for three days. Day and night, the first health poster of King of Hearts was born.
On July 21, an overwhelming "King of Hearts" whirlwind suddenly blew up in Wuhan in the middle of summer. Posters advertising the "King of Hearts" appeared on thousands of trams and buses almost simultaneously. , the slogan "Hello, China has a King of Hearts" spread like wildfire.
On September 14, "People's Daily" reported: "For half a century, porphyrin iron (heme iron), the world's best nutritional ingredient for treating iron deficiency anemia, has been affected by the extraction method. Due to restrictions, mass production has been impossible. Recently, Wuhan Heart K Group has adopted bioengineering technology to solve this problem."
On December 31, the Wuhan East Lake New Technology Development Zone Intangible Assets Appraisal Office organized seven well-known domestic experts to evaluate and demonstrate the technical value of the Heart K blood-promoting agent and confirmed that the Heart K blood-promoting agent The technical value of this high-tech biological product is RMB 68.02 million.
Hematogen K of Heart was selected by the National Science and Technology Commission as a National Torch Plan project, and the government allocated special funds for its promotion.
On October 11, the company signed an agreement with Nanhu Fishery on the joint venture development and construction of Lidao Garden, the first high-end residential community in Hubei Province.
In 1995
The group company established 153 sales companies across the country, with a sales network all over the country.
The group company has become one of the top 100 private enterprises in China.
K of Hearts is included in the national key high-tech enterprise group and the key project of the national Torch Plan.
Explore overseas markets such as Singapore, Thailand, and South Korea.
In order to seize the commanding heights of world science and technology, the group company invested 100 million yuan to find scientific and technological achievements. More than 100 of the more than 1,700 projects tendered have the prospect of further development.
1996
On June 30, 1996, national appraisers strictly adopted the "Income Present Value Method" and evaluated the assets of Heart K Group at 650 million yuan. Since July, K of Hearts has continued to develop rapidly, and its fixed assets and intangible assets have increased by hundreds of millions of yuan.
On August 6, the group company donated 1 million yuan to the Wuhan Municipal Government to the disaster-stricken area, and donated more than 3 million yuan throughout the year.
From August to December, the company organized a five-month production campaign, with the monthly production capacity exceeding 500 million.
From October 8th to 10th, Hubei Daily reported "Analysis of the Miracle of the K of Hearts" on the front page for three consecutive days, explaining the development ideas of the K of Hearts Group.
On November 23, the Wuhan Municipal Government called on the whole city: "Learn the King of Hearts internally and learn the Little Swan externally."
In 1996, 4 new products were developed, including 1 national new drug and 3 health foods. "Biological Protein Calcium" was approved by the National Science and Technology Commission in December 1996 and was included in the national Torch Plan promotion project.
Completed the full-year sales target one month ahead of schedule. Based on the analysis of economic indicators such as profits and taxes, sales collections, output value, and asset growth, Heart K Group ranks among the 15 extremely large industrial enterprises in Wuhan. group.
1997
According to the assessment by a national asset appraiser with securities business asset appraisal qualifications, the value of the overall intangible assets of the Heart K Group in 1997 reached 2.65 billion yuan.
From January to October, the group company’s monthly sales collection exceeded the 200 million yuan mark.
On April 7, the State Administration for Industry and Commerce approved the renaming of "Wuhan Hongtaokai Group Co., Ltd." to "Hongtaokai Group Co., Ltd." The company has become a national comprehensive large-scale joint-stock enterprise group without geographical name restrictions.
On June 26, Heart K Group was listed as a "Key High-tech Enterprise in the National Torch Plan" by the State Science and Technology Commission.
In 1998
Heart K Group ranked first in sales revenue and total profits and taxes in the national biological products industry.
On July 8, Heart K Group merged with Wuhan Ninth Pharmaceutical Factory and established Wuhan United Pharmaceutical Co., Ltd.
From July to October, Heart K Group donated more than 13 million yuan in donations and materials to fight floods.
In October, Heart K Group acquired the listed company Donghu High-tech Group Co., Ltd. and became the largest shareholder.
On November 25, Heart K Group invested 360 million yuan in the first phase, covering an area of ??350 acres, and laid the foundation stone for the Guannan Biopharmaceutical Base that complies with GMP standards. The base is listed as a key city project.
In November, the Heart K Group invested more than 80 million yuan to acquire and establish the Hubei Wuhan Heart K Professional Football Club. In August, the national rowing team was named the Chinese Hearts K Rowing Team.
In 1999
Researcher Xie Tianjian and other 13 experts collectively joined Wuhan East Lake High-tech Group Co., Ltd., a listed company controlled by the K of Hearts. This incident aroused strong social repercussions, and the central government Comrade Li Lanqing, member of the Standing Committee of the Political Bureau, fully affirmed the instructions given on June 12, 1999.
The Hubei Provincial Education Commission and the Heart K Group jointly established the "Outstanding College Students Chucai Award" in colleges and universities across the province. In November 1999, the first batch of 59 outstanding college students from universities in Hubei Province won the "Chu Cai Award".
On December 29, "K of Hearts" was recognized as a "China Famous Trademark" by the State Administration for Industry and Commerce.
The market share of Heart K’s blood-stimulating agent has ranked first in the industry in the country for three consecutive years.
2000
On February 23, Hubei Daily published the article "Creating Billionaires According to "Smart" Distribution" and launched a series of discussions on "Perspective on the Zhang Tingbi Phenomenon", which attracted dozens of people at home and abroad. Many media outlets rushed to reprint it, arousing strong social repercussions.
On April 13, Professor Zhuo Renxi, winner of the International Fellow Award and academician of the Chinese Academy of Sciences, cooperated with the Heart K Group to establish Wuhan Ruikang Biomaterials Co., Ltd. to develop Biomaterial products with the world's advanced level; on September 18, Professor Zhang Gaoyong, academician of the Chinese Academy of Engineering, signed a scientific and technological cooperation agreement with the Heart K Group on behalf of the China Institute of Daily Chemicals to jointly develop surfactant products with the world's advanced level. .
On June 12, the company awarded Wu Xiaolan, a doctoral student who returned from studying abroad, a new car. In December, 16 middle and senior managers of the company obtained Master of Business Administration (MBA) degrees from Asia International (Macau) Open University.
The group company has achieved good operating results and achieved its annual operating targets. Its sales revenue and profit and tax indicators have ranked first in the industry in the country for four consecutive years.
The group’s technological innovation projects have made significant progress. "Shengxuening Tablets" was approved by the State Food and Drug Administration as a new national traditional Chinese medicine Class II on November 21; the "Natural Propolis Antioxidant Technology and Industrialization Project" was listed as a 2000 national key scientific and technological innovation plan project; nano microcapsules were used The technology to improve the water solubility and stability of porphyrin iron has made a major breakthrough, filling the domestic gap and reaching the international leading level.
In the same year, the group company made significant progress in its multi-industry and sub-brand operations. The drug Huankai Yishenling is on the market, and Haosijia Porphyrin Iron VC functional drink is on the market; Lidao Garden has achieved good sales results, and "Lidao" has become a well-known brand in the real estate industry in Wuhan; Tianzitang series products are sold in the pilot market.
2001
On July 30, Chairman Xie Shengming and Professor Xie Tianjian represented Heart K Group and Kono Company respectively at the Kumho Group headquarters in South Korea, and had a meeting with Kumho Group Senior Vice President Park Shengyong signed a cooperation agreement. According to the agreement, the group company cooperates with Kumho to jointly research and develop plant growth gene projects.
On September 18, the "China Health Food Industry Statistical Data Release and Commendation Conference for 2000" was held in Beijing. The conference commended the top 50 companies including Heart K Group. The conference was hosted by the China Health Food Association.
Chairman Xie Shengming was appointed as a member of the Third Hubei Provincial People’s Government Advisory Committee.
The company has been recognized as a national enterprise technology center by the National Economic and Trade Commission, the Ministry of Finance, the State Administration of Taxation, and the General Administration of Customs.
In March 2002, the group company hired Roland Berger, an international management consulting firm, to diagnose the company, propose a guidance plan, improve the corporate governance structure, and comprehensively promote the reform of the marketing organizational structure. Two major changes have taken place in the marketing system: in the six key marketing areas across the country, the number of 230 sales-oriented subsidiaries has been adjusted to 22, direct sales activities have been completely withdrawn, and sales in various regions have been handed over to large dealers with professional standards. The subsidiary is mainly engaged in marketing and after-sales service supporting dealers. After screening, the number of dealers in these areas was reduced from thousands to less than 200.
On March 17, the China Industry and Enterprise Information Release Center of the National Bureau of Statistics released statistical information at the Great Hall of the People. Heart K blood-stimulating agent won the first place in sales of similar products in the national market in 2001. On November 30, Shengxuekang was reviewed and determined by the State Food and Drug Administration as two Chinese medicine varieties with "approved" national medicine brands, one is "Shengxuekang Mixture" and the other is "Blending Blood Tablets", and was approved as "one package, two products". A new variety of approval documents.
2003
On April 30 and May 2, Heart K Group Company donated 1.2 million and 280,000 yuan worth of SARS prevention and control headquarters in Hubei and Zhejiang provinces respectively. medicines to support the two provinces’ fight against SARS.
As of May 2003, the company has 102 products, including 7 national new drugs, 74 exclusively produced and traditional Chinese medicines, 5 health products converted into drugs, and 16 health foods. At the same time, it is developing There are 29 modern traditional Chinese medicines and health foods, and many projects have been included in the national key innovation plan.
In May, the National Development and Reform Commission approved Hongtao K Group’s national Class III new drug Danggui Shaoyao Granules as a national high-tech industrialization project with a total investment of 72 million yuan.
On September 19, the Ministry of Science and Technology awarded Heart K Group the honorary title of "Outstanding High-tech Enterprise of the Torch Plan".
In 2003, 3 of the 10 shareholders of Heart K Group Holdings Company split up.
In January 2004,
Heart K Group Co., Ltd. was officially recognized as a "Key Enterprise of the National Traditional Chinese Medicine Modern Science and Technology Industry (Hubei) Base".
On March 24, the company was rated as a national advanced private enterprise in employment and social security by the Ministry of Labor and Social Security and the All-China Federation of Industry and Commerce. In early May, the group company headquarters officially moved to Guannan Industrial Park, located in the "Optics Valley of China".
In September, Heart K Guannan Pharmaceutical Base officially passed the GMP certification of the State Food and Drug Administration.
2005
On December 15, the selection of "Leading Private Enterprises with Promoting Power in Hubei Province" for 2005 was announced, and Heart K Group was on the list.
2006
On February 17, Miao Wei, member of the Standing Committee of the Hubei Provincial Party Committee and Secretary of the Wuhan Municipal Party Committee, and his delegation made a special trip to inspect the Heart K Group. So far, Heart K Group has accumulated sales of nearly 10 billion yuan and paid more than 1 billion yuan in taxes to the country.
On April 29, 2005, Wuhan East Lake New Technology Development Zone held an annual award conference for entrepreneurs with outstanding contributions, and gave heavy awards to the 16 heads of production enterprises who ranked among the top in tax payment in 2005. Xie Shengming, chairman of Heart K Group, has an award-winning car.
In July, the 2006 Second China Quality Credit Summit was held in the Press Conference Hall of the Great Hall of the People in Beijing, and the Heart K Group was awarded the AAA national quality reputation honor.
2007
In February, the National Development and Reform Commission approved the innovation capability project of Heart K Group’s nationally recognized enterprise technology center: macroporous resin refining and purification project, with a total investment of 13.8 million yuan.
In March, the list of "Wuhan City's 2006 Advanced Enterprises in Industrial Economic Operation" was released, and Heart K Group Co., Ltd. was included on the list.
In 2007, the company's payment collection rate for shipments has been controlled at above 95%. Shengxuekang's distribution covers 8 provinces and 14 regions, which is at a relatively high level compared with historical data. Drugs represented by Shengxuekang have become an important platform for the development of pharmaceutical companies.
2008
On May 15, Heart K Group donated 1 million yuan of medicines to the earthquake-stricken area in Wenchuan County, Sichuan.
In May 2009,
The e-commerce platform of Heart K Group was put into operation and became a new sales platform for cosmetics and health food.
On September 4, the State Intellectual Property Office accepted the application for an invention patent for Heart K Group’s “double-drug quasi-brand” drug “Shengxuekang Mixture·Blood-Building Tablets”. The name of the invention patent is “A product for Blood-enhancing pharmaceutical composition and preparation method thereof.
In 2010
The company established a clinical promotion division and the drugs were sold in hospitals.
The company has accepted or obtained 10 national invention patents and 25 design patents.
On January 6, the foundation stone was laid for Guannan Fuxing Medical Park, the Wuhan National Bioindustry Base jointly built by Heart K Group and Fuxing Group. The planned total construction area is 290,000 square meters, with a total investment of 800 million yuan. It has international biological enterprise headquarters, scientific research incubator, biological diagnostic reagent production base, small and medium-sized biological enterprise base and related service supporting facilities.
In 2010, the group real estate company was grafted into a high position, with annual sales exceeding 700 million yuan.
2011
Heart K Chunpai e-commerce company was selected as one of the "Top Ten Honest Online Merchants in Hubei Province in 2011", ranking first in the industry in sales in the province.
The real estate company has added three new projects, with a construction area of ??more than 500,000 square meters.
The pharmaceutical company was awarded the government's advanced environmental protection unit, and the sewage treatment online monitoring Internet of Things system was put into use.
The national trial standards for Shengxuekang drugs were formalized, the local standards for black-bone chicken blood-nourishing and Chuiyin tea were upgraded to national standards, and 17 new standards for health foods and nutritious foods passed review and were put into use.
2012
On February 24, Heart K Group e-commerce company donated 1 million yuan to the Hubei Provincial Women and Children's Foundation to support left-behind children and women in society. This donation was paid by the official Taobao flagship store of Heart K, making it the largest single charity donation by an online store in my country.
Hongtao K Shengxuekang has been promoted in hospitals. Medical experts say that Hongtao K Shengxuekang is irreplaceable in the treatment of iron deficiency anemia.
Heart K Group launched a love-based exam assistance campaign and donated blood-enhancing and brain-boosting products to college entrance examination students in some middle schools in Hubei, Shaanxi, Guangdong, Zhejiang, etc.: iron porphyrin DHA, as well as the "College Entrance Examination Top Scorer's Guide" and " Special notebooks for candidates to prepare for exams, and other study equipment and daily necessities. A college entrance examination health consultation hotline has been opened nationwide to provide candidates and parents with pre-exam health guidance, psychological stress reduction, exam preparation counseling and other consulting services.
In July, the sales of Heart K brand health food on mainstream e-commerce platforms were leading the entire network.